Tokyo, Japan, Published date 6 December, 2019
Hitachi to Provide CNAO with Proton Therapy SystemSelect category Healthcare
Hitachi to Provide CNAO with Proton Therapy System
Tokyo, December 6, 2019 --- Hitachi, Ltd. (TSE:6501, “Hitachi”) today announced that it has entered into an agreement to provide Centro Nazionale di Adroterapia Oncologica (CNAO) with its proton therapy system.
In comprehensive public tender process, Hitachi has been selected to provide proton therapy system with latest technologies including advanced scanning technology to irradiate even tumors with complex shapes with high precision.
MADISON, Wis. U.S., 27 July 2022
Hitachi Chosen as Proton Therapy Provider for UW Health Eastpark Medical CenterRead more Select category Healthcare Manufacturing
Tokyo, Japan, 6 January 2021
Olympus and Hitachi Announce Long-Term Business AllianceRead more Select category Corporate News Healthcare Research & Development